InvestSMART

Jayex Healthcare Limited (ASX: JHL) - Announcements

- Current share price for JHL : $0.032

ASX company news and announcements for Jayex Healthcare Limited (JHL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Jayex Healthcare Limited (JHL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Jayex Healthcare Limited (JHL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Jayex Healthcare Limited (JHL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- AGM Presentation 31 Jul 2020 4:42PM $0.031 $0.032 risen by 3.23%
- Chairman's Address to Shareholders 31 Jul 2020 4:26PM $0.031 $0.032 risen by 3.23%
- Proposed issue of Securities - JHL 31 Jul 2020 8:25AM $0.031 $0.032 risen by 3.23%
- Proposed Convertible Note Issue and Debt Conversion 31 Jul 2020 8:25AM $0.031 $0.032 risen by 3.23%
- Change of Auditor 27 Jul 2020 8:22AM $0.039 $0.032 fallen by 17.95%
- June 2020 Quarterly Update and Appendix 4C 24 Jul 2020 9:52AM $0.040 $0.032 fallen by 20%
- Change of Director's Interest Notice 1 Jul 2020 8:58AM $0.018 $0.032 risen by 77.78%
- Change of Director's Interest Notice 30 Jun 2020 2:10PM $0.018 $0.032 risen by 77.78%
- Resignation of CEO and Managing Director 29 Jun 2020 9:39AM $0.021 $0.032 risen by 52.38%
- Notice of Annual General Meeting/Proxy Form 18 Jun 2020 4:53PM $0.021 $0.032 risen by 52.38%
- LSH: Licence Agreement with Jayex Healthcare 11 Jun 2020 9:41AM $0.025 $0.032 risen by 28%
- Jayex signs Licence Agreement with Lifespot Health 11 Jun 2020 9:41AM $0.025 $0.032 risen by 28%
- Revised AGM Date and Director Nomination Closing Date 5 Jun 2020 8:51AM $0.023 $0.032 risen by 39.13%
- AGM Date and Director Nomination Closing Date 3 Jun 2020 8:26AM $0.023 $0.032 risen by 39.13%
- JHL receives funding in form of COVID-19 support 19 May 2020 11:05AM $0.022 $0.032 risen by 45.45%
- March 2020 Quarterly Update and Appendix 4C 28 Apr 2020 8:53AM $0.018 $0.032 risen by 77.78%
- COVID-19 (Coronavirus Pandemic) Market Update - Correction 16 Apr 2020 8:37AM $0.017 $0.032 risen by 88.24%
- COVID-19 (Coronavirus Pandemic) Market Update 9 Apr 2020 10:10AM $0.014 $0.032 risen by 128.57%
- Deferral of Annual General Meeting 25 Mar 2020 8:26AM $0.015 $0.032 risen by 113.33%
- Appendix 4G and Corporate Governance Statement 24 Mar 2020 4:27PM $0.015 $0.032 risen by 113.33%
- Annual Report 24 Mar 2020 4:22PM $0.015 $0.032 risen by 113.33%
- Section 708A Notice and Appendix 2A 4 Mar 2020 2:34PM $0.019 $0.032 risen by 68.42%
- Section 708A Notice and Appendix 2A 28 Feb 2020 10:46AM $0.018 $0.032 risen by 77.78%
- Preliminary Final Report 28 Feb 2020 9:57AM $0.020 $0.032 risen by 60%
- Response to ASX Appendix 4C Query 10 Feb 2020 9:39AM $0.024 $0.032 risen by 33.33%

51 - 75 of 233 results

Page 3 of 10

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.